Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/25 17:17 | 8/11/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 2 | S.d | -5,291 | 634.18 | 0 | -8 | 18 | D | |||||||||||||||
8/12/25 17:00 | 8/8/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | 1 | S.d | -3,551 | 651.60 | 0 | -5 | 6 | D | |||||||||||||||
8/8/25 20:38 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 1 | S.d | -18,492 | 631.98 | 0 | -29 | 83 | D | |||||||||||||||
8/8/25 20:37 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | 1 | S.d | -5,280 | 627.74 | 0 | -8 | 8 | D | |||||||||||||||
5/23/25 17:00 | 5/21/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | 1 | S.d | -1,183 | 512.97 | 0 | -2 | 2 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |